rAAV vector prominin-1 gene therapy (Technische Universitat Dresden)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NamerAAV vector prominin-1 gene therapy (Technische Universitat Dresden)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionCD133 stimulants
TargetsCD133
Therapy Area/IndicationsRetinal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTechnische Universitat Dresden
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTechnische Universitat Dresden
Active IndicationsN/A
Inactive IndicationsRetinal Diseases

Other Information

ATC CodeN/A
Related LinksN/A